Firm in NHS row over cystic fibrosis drug paid almost no UK tax

6 March 2019 - European division of Vertex made loss while paying large sum to profitable US owner. ...

Read more →

Drug companies and doctors battle over the future of faecal transplants

3 March 2019 - As pharmaceutical companies seek to profit from the curative wonders of human faeces, doctors worry about new ...

Read more →

No one knows the true cost of medicines, and blaming other countries won't help

3 March 2019 - It’s not often that the Trump administration and the anti-poverty NGO Oxfam find themselves singing from the ...

Read more →

Drug industry CEOs say the problem isn’t high prices, it’s how misunderstood they are

28 February 2019 - It’s been a good week for political theatre.  ...

Read more →

“Repurposing” off-patent drugs offers big hopes of new treatments

28 February 2019 - Towards the end of 2014 a 66-year-old British man named Alistair had a seizure. A scan ...

Read more →

Senator: big pharma is 'morally repugnant'

26 February 2019 - Seven executives of top pharmaceutical companies were grilled before a congressional panel Tuesday about the nation's ...

Read more →

Pharma industry swamped with no-deal Brexit info, says BIA

27 February 2019 - Deluge comes just as prime minister hints at delay. ...

Read more →

Former Novartis executive wins $1.5 million after claiming she was fired for complaining about a study

26 February 2019 - Min Amy Guo, who had been executive director of the Health Economics and Outcomes Research Group, objected ...

Read more →

How pharma lost its edge in Washington

25 February 2019 - Major drug company CEOs are about to appear before Congress to address drug pricing—for the first time ...

Read more →

Hearings on 'sky-high' drug prices show how little has changed in 60 years

25 February 2019 - Kenneth Frazier, CEO of pharma giant Merck, is set to face senators Tuesday who say drug ...

Read more →

'Getting away with murder' in drug pricing

24 February 2019 - President Donald J. Trump has made it a promise to lower drug prices for all Americans. ...

Read more →

It’s time for pharmaceutical companies to have their tobacco moment

24 February 2019 - Elected officials have made a lot of noise about the cost of prescription drugs. Now they must ...

Read more →

Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model in a pharmaceutical company

21 February 2019 - Evidence requirements and assessment methods access differ between health technology assessment agencies.  ...

Read more →

High pharma margins squeeze health care systems

19 February 2019 - The WHO found that for every dollar invested in cancer research, pharmaceutical companies earned on average $14.50 ...

Read more →

The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress

21 February 2019 - One’s a college dropout. One’s a self-proclaimed street fighter. And one survived a presidential tweetstorm. ...

Read more →